一个分子蓝图,以准ALK基因融合在质母细胞瘤

Stephen C Mack1,2, Kelsey C Bertrand2,3

  • 1Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.

概括

无细胞淋巴瘤激酶 (ALK) 基因融合是婴儿质母细胞瘤 (GBM) 的关键驱动因素. 识别这些ALK重组有助于确定那些可以从向ALK疗法中受益的患者.